ALAMEDA, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Xenogen Corporation , maker of advanced imaging systems designed to accelerate drug discovery and development, today announced that David W. Carter, chairman and chief executive officer, and Pamela Reilly Contag, Ph.D., president, will present at the CIBC World Markets 16th Annual Healthcare Conference to be held November 7-9, 2005 at The Waldorf-Astoria in New York City.
Xenogen’s presentation will take place at 10:30 a.m. Eastern Time on Wednesday, November 9, 2005. There will be a live audio webcast of the presentation, which will be accessible through a link posted on the investor relations section of Xenogen’s website at www.xenogen.com. The webcast will be available for replay on Xenogen’s website for two weeks through November 23, 2005.
About Xenogen Corporation
Xenogen Corporation is a leading biotechnology company offering an integrated suite of biophotonic real-time in vivo imaging and genetic modification technologies that can help expedite drug discovery and development, and significantly reduce the cost and time to market for new therapies. Xenogen’s VivoVision(TM) Systems non-invasively illuminate and monitor biological processes within living mammals, at the molecular level, in real time. The technology is designed provide higher quality in vivo data earlier in the drug discovery and development process. VivoVision(TM) Solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. VivoVision(TM) Biosciences represents more than 15 years of experience in the creation and characterization of animal models, including genetic modifications, comprehensive phenotyping, compound profiling and custom design and production of light producing cells, microorganisms and animals.
More information is available at www.xenogen.com.
NOTE: Xenogen(R), Living Image(R), VivoVision(TM) and IVIS(R) are trademarks of Xenogen Corporation.
Xenogen Corporation
CONTACT: William A. Albright, Chief Financial Officer of XenogenCorporation, +1-510-291-6100
Web site: http://www.xenogen.com/